key: cord-0860130-oxyss7hz authors: Jiang, Peng; Klemeš, Jiří Jaromír; Van Fan, Yee; Fu, Xiuju; Tan, Raymond R.; You, Siming; Foley, Aoife M. title: Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective date: 2021-06-30 journal: Energy (Oxf) DOI: 10.1016/j.energy.2021.121315 sha: cb10d90048b1a890b7fc7bf91928fbd5023c6d1d doc_id: 860130 cord_uid: oxyss7hz Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolonged immunisation campaign for COVID-19 is likely. The impacts are geographically dispersed across sectors and regions, creating real and virtual 4E footprints that occur at different timescales. Decision-makers in industry and governments have to act, unify, resolve, and work together to implement more sustainable COVID-19 vaccination management globally and locally to minimise the 4E footprints. Potential practices include using renewable energy in production, storage, transportation and waste treatment, using better product design for packaging, using the Internet of Things (IoT) and big data analytics for better logistics, using real-time database management for better tracking of deliveries and public vaccination programmes, and using coordination platforms for more equitable vaccine access. These practices raise global challenges but suggest solutions with a 4E perspective, which could mitigate the impacts of global vaccination campaigns and prepare sustainably for future pandemics and global warming. but suggest solutions with a 4E perspective, which could mitigate the impacts of global current number of vaccinated people is still far from this target. If managed properly, 71 significant health and economic outcomes are apparent after introducing COVID-19 72 vaccination [ 12 ] . Rapid scale-up of vaccination could pose serious sustainability 73 challenges to various sectors, e.g. the pharmaceutical sector [ 13 ] , the biotech 74 manufacturing sector [14] , the logistics sector [15] and the waste management sector 75 [16] . Due to the gravity of the pandemic, the need to deploy vaccines has taken priority 200,000 pallets, and 15,000 flights are needed to deliver 10 billion (10 9 ) vaccine doses 91 J o u r n a l P r e -p r o o f multimodal cold chain logistics, the wastage rate of vaccines could be up to 30%, 116 even in some developed countries [27] . The need for excess production and 117 reallocation to compensate for the massive wastage would significantly inflate the 118 4E impacts and prolong the global recovery, entailing unnecessary depletion of 119 resources. (ii) The last-mile logistics has already been problematic in the USA [28] , and wastage 121 would be even worse in lower-income countries. For example, less than 50% of Africa [ 29 ] . Many countries have limited readiness for mass vaccination. For 125 example, only 59% of respondents agreed or strongly agreed that a logistics 126 management information system that supports vaccination effectively needs 127 vaccine demand forecasting [29] . (iv) The environmental impact of the sudden surge in plastics [33] , medical waste [16] 139 and single-use personal protective equipment (PPE) [34] has been severe since 140 the start of the pandemic. Without proper management guidelines, the vaccination 141 campaigns could be followed by a looming waste crisis from syringes, needles, 142 sharps containers, vaccine vials, and packing materials [35] . (v) The long-term unsustainable financial and economic implications of the 144 vaccination campaign should not be ignored [36] . Vaccination is necessary to end vaccines is not high (i.e. 71.5%), which also presents significant spatial differences [43] , Gavi, is one channel to mitigate social inequality and discrepancy issues. Distributing vaccines to more than 100 low-income countries, cost-sharing WHO, 2021. WHO Coronavirus (COVID-19) Dashboard Impact of COVID-19 on the social, economic, environmental and energy domains: Lessons learnt from a global pandemic Literature survey on the relationships between energy, environment and economic growth 0 1. Impa o CO ID-19 on energy demand and consumption: Challenges, lessons and emerging opportunities Indirect effects of COVID-19 on the environment Using social and behavioural science to support COVID-19 pandemic response Brazilian town experiment shows mass vaccination can wipe out COVID-19 Data, 2021. Coronavirus (COVID-19) Vaccinations Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation. The Lancet Infectious Diseases Can global pharmaceutical supply chains scale up sustainably for the COVID-19 crisis Vaccine market and production capabilities in the Americas Mi imi i e pre e a d future plastic waste, energy and environmental footprints related to COVID-19 Delivering pandemic resilience: how to secure stable supply chains for vaccines and medical goods during the covid-19 crisis and future health emergencies Refrigeration of COVID-19 vaccines: ideal storage characteristics, energy efficiency and environmental impacts of various vaccine options Optimizing energy or a ' ree Future scenarios for the COVID-19 pandemic As vaccines emerge, a global waiting game begins How COVID vaccines are being divvied up around the world SARS-CoV-2 variants and ending the COVID-19 pandemic South Africa suspends use of AstraZeneca's COVID-19 vaccine after it fails to clearly stop virus variant CMMID COVID-19 Working Group, 2021. The potential for vaccination-induced herd immunity against the SARS-CoV-2 B. 1.1. 7 variant Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States COVID vaccine: some waste is normal -but here's how it is being kept to a minimum Accessed 2 Last-mile logistics of covid vaccination-the role of health care organisations Africa's Covid-19 Vaccine Supply Chain and